Home

SHL - Morgan Stanley rates the stock as Overweight

PUBLISHED

2021-11-08

Content

Morgan Stanley upgrades its EPS forecasts for Sonic Healthcare on global data showing ongoing elevation of covid-19 testing. The broker lifts its target price to $46.10 from $45.50 and retains its Overweight rating. Industry view: In-line.

The analyst assesses the company's risk reward payoff compares favourably to alternatives in the Health Care sector.

Sector: Health Care Equipment & Services.

 

Target price is $46.10.Current Price is $40.91. Difference: $5.19 - (brackets indicate current price is over target). If SHL meets the Morgan Stanley target it will return approximately 11% (excluding dividends, fees and charges - negative figures indicate an expected loss).